Laurus Labs Ltd. (LAURUSLABS) Share Price Surges 5.95% in Today’s Trading

Laurus Labs Ltd. Share Price rises 5.95% to Rs 1,697.7 today, marking a significant gain in the large-cap category.

Laurus Labs Ltd. Share Price has seen a notable increase today, rising by 5.95% to reach Rs 1,697.7. This significant movement comes as the company, with a market capitalization of Rs 86,564.19 crore, clears the qualifying threshold set for the large-cap category, which is 3%. The stock opened at Rs 1,631.8 and reached a high of Rs 1,702, demonstrating strong upward momentum throughout the trading session. This price action places Laurus Labs Ltd. among the top gainers in the market today.

The healthcare sector, in which Laurus Labs operates, has been witnessing varied performance, and today’s rally in Laurus Labs Ltd. Share Price highlights the company’s potential within this competitive landscape. Despite the absence of a specific catalyst in the supplied data, the stock’s performance today is noteworthy for investors tracking the healthcare sector.

Laurus Labs Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,697.7
Previous Close	Rs 1,602.3
Today's Change	+Rs 95.4 (+5.95%)
Day Open	Rs 1,631.8
Day High	Rs 1,702
Day Low	Rs 1,618.8
Current Volume (BSE)	6,44,770
BSE Traded Volume	6,44,770
NSE Traded Volume	42,71,582
Combined NSE + BSE Volume	49,16,352
Turnover	Rs 109.46 crore
Market Capitalisation	Rs 86,564.19 crore
Market Cap Category	Large Cap
Qualifying Threshold Cleared	3%

Today’s trading session has been particularly favorable for Laurus Labs Ltd., with the share price increasing by Rs 95.4 from the previous close of Rs 1,602.3. The stock opened at Rs 1,631.8, reached a high of Rs 1,702, and a low of Rs 1,618.8, before closing at Rs 1,697.7. The total turnover for the day was Rs 109.46 crore, with a total volume of 49,163,52 shares traded across BSE and NSE.

As a large-cap company, Laurus Labs Ltd. needed to surpass a 3% price rise to qualify as a significant mover, and today’s 5.95% increase comfortably clears this threshold. The substantial trading volume, with a volume ratio indicating heightened market participation, underscores the market’s interest in the stock today. This price action analysis reveals a robust demand for Laurus Labs Ltd. shares, positioning it as a key player in today’s market dynamics.

Laurus Labs Ltd. Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 86,564.19 crore
P/E Ratio	31.07x
P/B Ratio	2.36x
ROE	29.2%
ROCE	27.13%

Laurus Labs Ltd. was valued at a P/E ratio of 31.07x, a P/B ratio of 2.36x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 29.2% and ROCE of 27.13%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Laurus Labs Ltd. is valued with a market capitalization of Rs 86,564.19 crore and an enterprise value that reflects its significant presence in the healthcare sector. The company’s P/E ratio stands at 31.07, which is above the sector median of 20.79 but aligns closely with the peer average. This suggests that while Laurus Labs is trading at a premium compared to the sector median, it remains competitive within its peer group.

The company’s P/B ratio of 2.36 is slightly above the sector median of 1.89, indicating a higher valuation relative to its book value. Laurus Labs Ltd. demonstrates strong profitability metrics with an ROE of 29.2% and an ROCE of 27.13%, both significantly above the sector averages of 14.41% and 16.32%, respectively. These figures highlight the company’s efficient use of equity and capital, contributing to its robust financial performance.

Despite ‘s financial health and market positioning. Investors should consider these factors when evaluating the company’s potential for future growth and profitability.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Companies in Benchmark	203
Company P/E Ratio	31.07x
Benchmark Median P/E	20.79x
Benchmark Average P/E	67.01x
Benchmark P/E Range	0x to 3,482.29x
Companies with P/E Data	203
Company P/B Ratio	2.36x
Benchmark Median P/B	1.89x
Company ROE	29.2%
Benchmark Median ROE	10.69%
Company ROCE	27.13%
Benchmark Median ROCE	13.12%
Company Market Capitalisation	Rs 86,564.19 crore
Benchmark Median Market Cap	Rs 130.49 crore

Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare. The numerical benchmark uses 203 same sector companies from the supplied master-data set.

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 31.07x, which is above the benchmark median of 20.79x, a difference of +49.45%. The benchmark contains 203 companies with P/E data, ranging from 0x to 3,482.29x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Laurus Labs Ltd. (LAURUSLABS) has a ROE of 29.2%, which is above the benchmark median of 10.69%, a difference of +173.15%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 27.13%, which is above the benchmark median of 13.12%, a difference of +106.78%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Laurus Labs Ltd. operates within the healthcare sector, which comprises 203 companies. The sector’s P/E ratio ranges from 0 to 3,482.29, with a median of 20.79, indicating a diverse valuation landscape. Laurus Labs Ltd.’s P/E ratio of 31.07 places it above the sector median, suggesting a higher valuation relative to many of its peers.

The sector’s P/B ratio median is 1.89, with Laurus Labs Ltd. slightly exceeding this at 2.36. The company’s ROE of 29.2% and ROCE of 27.13% are well above the sector medians of 10.69% and 13.12%, respectively, showcasing its superior profitability and operational efficiency.

With a market capitalization of Rs 86,564.19 crore, Laurus Labs Ltd. is a significant player in the healthcare sector, where the median market cap is Rs 130.49 crore. This positions Laurus Labs Ltd. as a leader in terms of size and financial performance, making it a company of interest for investors looking at the healthcare industry.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Morepen Laboratories Ltd.	MOREPENLAB	2,947.44	31.07	2.36	29.2	27.13
Dishman Carbogen Amcis Ltd.	DCAL	2,885.59	29.61	0.43	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,881.37	42.78	8.71	28.21	26.35
Beta Drugs Ltd.	BETA	2,567.04	61.88	8.27	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,425.38	34.6	7	-2.6	16.92

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 31.07x compared with the displayed peer median of 34.6x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 29.2% compares with a peer median of 18.65% across the companies shown in the table. ROCE stood at 27.13% versus the displayed peer median of 22.17%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 86,564.19 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

In comparison to its peers, Laurus Labs Ltd. holds a strong position. Morepen Laboratories Ltd., with a market cap of Rs 2,947.44 crore, shares the same P/E and P/B ratios as Laurus Labs, indicating similar valuation metrics. Dishman Carbogen Amcis Ltd. and Kwality Pharmaceuticals Ltd. have lower market caps but present varied P/E and ROE figures, reflecting different valuation and profitability profiles.

Beta Drugs Ltd. and Dr Agarwals Eye Hospital Ltd. also present diverse financial metrics, with Beta Drugs Ltd. showing a higher P/E ratio of 61.88 and Dr Agarwals Eye Hospital Ltd. having a negative ROE. These comparisons highlight Laurus Labs Ltd.’s competitive edge in terms of profitability and market valuation within the healthcare sector.

Why Investors Are Watching Laurus Labs Ltd.

Investors are closely monitoring Laurus Labs Ltd. due to its significant price rise today and its strong market position in the healthcare sector.

• Price Action: A 5.95% increase in share price today.
• Technical Position: Strong market participation with high volume.
• Fundamental Context: Robust ROE and ROCE metrics.
• Sector Positioning: Leading market cap in the healthcare sector.

As Laurus Labs Ltd. continues to demonstrate financial strength and market leadership, investors should keep an eye on its performance and sector developments for potential opportunities.

About Laurus Labs Ltd.

Laurus Labs Ltd. is a prominent player in the healthcare sector, focusing on the development and manufacturing of active pharmaceutical ingredients (APIs), formulations, and biotechnology products. The company operates across multiple segments, including generic APIs, formulations, and synthesis, catering to a global clientele.

With a strong emphasis on research and development, Laurus Labs Ltd. has established itself as a leader in the pharmaceutical industry, leveraging its expertise to deliver high-quality products. The company’s robust financial performance and strategic market positioning make it a key player in the healthcare sector.

Track Laurus Labs Ltd. Share Price on Univest

Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track Laurus Labs Ltd. Share Price on Univest for real-time updates on share price, technical indicators, fundamental ratios, and market insights. Univest provides comprehensive data to help investors make informed decisions based on the latest market trends and company performance.

Frequently Asked Questions

What is the current share price of Laurus Labs Ltd.?

Ans. The current share price of Laurus Labs Ltd. is Rs 1,697.7, reflecting a 5.95% increase from the previous close of Rs 1,602.3. The stock moved 5.95% during the session. The intraday range extended from Rs 1,618.8 to Rs 1,702.

How much did Laurus Labs Ltd. share price increase today?

Ans. Laurus Labs Ltd. share price increased by 5.95% today, rising from Rs 1,602.3 to Rs 1,697.7. The stock moved 5.95% during the session. The intraday range extended from Rs 1,618.8 to Rs 1,702.

What is the market capitalization of Laurus Labs Ltd.?

Ans. Laurus Labs Ltd. has a market capitalization of Rs 86,564.19 crore, positioning it as a large-cap company in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 31.07x.

What is Laurus Labs Ltd.'s P/E ratio?

Ans. Laurus Labs Ltd.'s P/E ratio is 31.07, which is above the sector median of 20.79, indicating a premium valuation. The company trades at a P/E ratio of 31.07x. Its P/B ratio is 2.36x.

How does Laurus Labs Ltd.'s ROE compare to the sector?

Ans. Laurus Labs Ltd.'s ROE of 29.2% is significantly higher than the sector average of 14.41%, showcasing strong profitability. ROE stands at 29.2%. ROCE stands at 27.13%. The relevant peer median ROE is 10.69%.

Who are Laurus Labs Ltd.'s peers?

Ans. Laurus Labs Ltd.'s peers include Morepen Laboratories Ltd., Dishman Carbogen Amcis Ltd., and Kwality Pharmaceuticals Ltd., among others. Comparable listed companies include Morepen Laboratories Ltd., Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd.

What is Laurus Labs Ltd.'s P/B ratio?

Ans. Laurus Labs Ltd.'s P/B ratio is 2.36, slightly above the sector median of 1.89, indicating a higher valuation relative to its book value. The company trades at a P/E ratio of 31.07x.

How does Laurus Labs Ltd.'s ROCE compare to the sector?

Ans. Laurus Labs Ltd.'s ROCE of 27.13% is well above the sector average of 16.32%, highlighting efficient capital utilization. ROE stands at 29.2%. ROCE stands at 27.13%. The relevant peer median ROE is 10.69%.